|
1
|
Rapidis AD, Givalos N, Gakiopoulou H,
Faratzis G, Stavrianos SD, Vilos GA, Douzinas EE and Patsouris E:
Adenoid cystic carcinoma of the head and neck. Clinicopathological
analysis of 23 patients and review of the literature. Oral Oncol.
41:328–335. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Su BH, Qu J, Song M, Huang XY, Hu XM, Xie
J, Zhao Y, Ding LC, She L, Chen J, et al: NOTCH1 signaling
contributes to cell growth, anti-apoptosis and metastasis in
salivary adenoid cystic carcinoma. Oncotarget. 5:6885–6895. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ding LC, Huang XY, Zheng FF, Xie J, She L,
Feng Y, Su BH, Zheng DL and Lu YG: FZD2 inhibits the cell growth
and migration of salivary adenoid cystic carcinomas. Oncol Rep.
35:1006–1012. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang CY, Zhao YX, Xia RH, Han J, Wang BS,
Tian Z, Wang LZ, Hu YH and Li J: RASSF1A promoter hypermethylation
is a strong biomarker of poor survival in patients with salivary
adenoid cystic carcinoma in a Chinese population. PLoS One.
9:e1101592014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu X, Zhang Y, Ren W and Rao G: erbB2
gene silencing and its effect on PTEN in SACC-83salivary adenoid
cystic carcinoma cells. Oncol Rep. 24:1291–1296. 2010.PubMed/NCBI
|
|
6
|
Shimoda M, Sugiura T, Imajyo I, Ishii K,
Chigita S, Seki K, Kobayashi Y and Shirasuna K: The T-box
transcription factor Brachyury regulates epithelial-mesenchymal
transition in association with cancer stem-like cells in adenoid
cystic carcinoma cells. BMC Cancer. 12:3772012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu J, Shao C, Tan ML, Mu D, Ferris RL and
Ha PK: Molecular biology of adenoid cystic carcinoma. Head Neck.
34:1665–1677. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Laurie SA, Ho AL, Fury MG, Sherman E and
Pfister DG: Systemic therapy in the management of metastatic or
locally recurrent adenoid cystic carcinoma of the salivary glands:
A systematic review. Lancet Oncol. 12:815–824. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bell D, Bell A, Roberts D, Weber RS and
El-Naggar AK: Developmental transcripti-on factor EN1-a novel
biomarker in human salivary gland adenoid cystic carcinoma. Cancer.
118:1282–1292. 2012. View Article : Google Scholar
|
|
10
|
O'Toole PJ, Inoue T, Emerson L, Morrison
IE, Mackie AR, Cherry RJ and Norton JD: Id proteins negatively
regulate basic helix-loop-helix transcription factor function by
disrupting subnuclear compartmentalization. J Biol Chem.
278:45770–45776. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Healey MA, Deaton SL, Alder JK,
Winnepenninckx V, Casero RA Jr and Herman JG: Id1 overexpression is
independent of repression and epigenetic silencing of tumor
suppressor genes in melanoma. Epigenetics. 5:410–421. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yap WN, Zaiden N, Tan YL, Ngoh CP, Zhang
XW, Wong YC, Ling MT and Yap YL: Id1, inhibitor of differentiation,
is a key protein mediating anti-tumor responses of
gamma-tocotrienol in breast cancer cells. Cancer Lett. 291:187–199.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dong Z, Liu S, Zhou C, Sumida T, Hamakawa
H, Chen Z, Liu P and Wei F: Overexpression of Id-1 is associated
with tumor angiogenesis and poor clinical outcome in oral squamous
cell carcinoma. Oral Oncol. 46:154–157. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhu B, Song C and Wang P: Expression and
clinical significance of ID1 in gastric cancer. J Shanghai Jiao
tong Med Univ(Med Sci). 33:298–302. 2013.
|
|
15
|
Sun L, Li X and Liu G: Expression of Id1
and Id3 in endometrial carcinoma and their roles in regulating
biological behaviors of endometrial carcinoma cells in vitro. J
South Med Univ. 33:812–818. 2013.
|
|
16
|
Chen YY, Zhang S and Jiang ZQ: Expression
and clinical significance of Id-1, −3 in cervical intraepithelial
neoplasia and cervical sqamous cell cancer. Chin J Obstet Gynecol
Pediatr. 10:177–180. 2014.
|
|
17
|
Chen Y, Yang G and Yang ZH: Effect of DNA
binding protein inhibitor Id1 on the proliferation of osteosarcoma
cells. J Trop Med. 14:71–74. 2014.
|
|
18
|
Rothschild SI, Kappeler A, Ratschiller D,
Betticher DC, Tschan MP, Gugger M and Gautschi O: The stem cell
gene ‘inhibitor of differentiation 1’ (ID1) is frequently expressed
in non-small cell lung cancer. Lung Cancer. 71:306–311. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li Y, Liu Y, Zhou J, Dong SZ and Jin Y:
Expression of Id1 and its correlation with tumor angiogenesis in
salivary adenoid cystic carcinoma. J Clin Stomatol. 27:343–345.
2011.
|
|
20
|
Xei W, Li X, Ren G and Guo W: Expression
and importance of inhibitor of DNA binding helix-loop-helix protein
in salivary adenoid cystic carcinoma. Br J Oral Maxillofac Surg.
48:434–437. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mellick AS, Plummer PN, Nolan DJ, Gao D,
Bambino K, Hahn M, Catena R, Turner V, McDonnell K, Benezra R, et
al: Using the transcription factor inhibitor of DNA binding 1 to
selectively target endothelial progenitor cells offers novel
strategies to inhibit tumor angiogenesis and growth. Cancer Res.
70:7273–7282. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Langenfeld E, Deen M, Zachariah E and
Langenfeld J: Small molecule antagonist of the bone morphogenetic
protein type I receptors suppresses growth and expression of Id1
and Id3 in lung cancer cells expressing Oct4 or nestin. Mol Cancer.
12:1292013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yu X, Xu X, Han B and Zhou R: Inhibitor of
DNA Binding-1 overexpression in prostate cancer: Relevance to tumor
differentiation. Pathol Oncol Res. 15:91–96. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ling YX, Tao J, Fang SF, Hui Z and Fang
QR: Down regulation of Id1 by small interfering RNA in prostate
cancer PC3 cells in vivo and in vitro. Eur J Cancer Prev. 20:9–17.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ciarrocchi A, Piana S, Valcavi R, Gardini
G and Casali B: Inhibitor of DNA binding-1 induces mesenchymal
features and promotes invasiveness in thyroid tumor cells. Eur J
Cancer. 47:934–945. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pillai S, Rizwani W, Li X, Rawal B, Nair
S, Schell MJ, Bepler G, Haura E, Coppola D and Chellappan S: ID1
facilitates the growth and metastasis of non-small cell lung cancer
in response to nicotinic acetylcholine receptor and epidermal
growth factor receptor signaling. Mol Cell Biol. 31:3052–3067.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gumireddy K, Li A, Kossenkov AV, Cai KQ,
Liu Q, Yan J, Xu H, Showe L, Zhang L and Huang Q: ID1 promotes
breast cancer metastasis by S100A9 regulation. Mol Cancer Res.
12:1334–1343. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Asp J, Brantsing C, Lövstedt K, Benassi
MS, Inerot S, Gamberi G, Picci P and Lindahl A: Evaluation of p16
and Id1 status and endogenous reference genes in human
chondrosarcoma by real-time PCR. Int J Oncol. 27:1577–1582.
2005.PubMed/NCBI
|
|
30
|
Zheng W, Wang H, Xue L, Zhang Z and Tong
T: Regulation of cellular senescence and p16 (INK4a) expression by
Id1 and E47 proteins in human diploid fibroblast. J Biol Chem.
279:31524–31532. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ling MT, Lau TC, Zhou C, Chua CW, Kwok WK,
Wang Q, Wang X and Wong YC: Overexpression of Id1 in prostate
cancer cells promotes angiogenesis through the activation of
vascular endothelial growth factor (VEGF). Carcinogenesis.
26:1668–1676. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li X, Bian Y, Takizawa Y, Hashimoto T,
Ikoma T, Tanaka J, Kitamura N, Inagaki Y, Komada M and Tanaka T:
ERK-dependent downregulation of Skp2 reduces Myc activity with HGF,
leading to inhibition of cell proliferation through a decrease in
Id1 expression. Mol Cancer Res. 11:1437–1447. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cheng YJ, Tsai JW, Hsieh KC, Yang YC, Chen
YJ, Huang MS and Yuan SS: Id1 promotes lung cancer cell
proliferation and tumor growth through Akt-related pathway. Cancer
Lett. 307:191–199. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yang G, Zhang Y, Xiong J, Wu J, Yang C,
Huang H and Zhu Z: Downregulation of Id1 by small interfering RNA
in gastric cancer inhibits cell growth via the Akt pathway. Mol Med
Rep. 5:1075–1079. 2012. View Article : Google Scholar : PubMed/NCBI
|
